all of this drama over a 79% efficacy rate that ended up being...76%?https://www.astrazeneca.com/media-centre/press-releases/2021/azd1222-us-phase-iii-primary-analysis-confirms-safety-and-efficacy.html …
-
-
If the WaPo report is right & it was swinging between 69 & 79 month on month after enough interim events, they couldn't be sure of that, I guess. (Does make you wonder about individuals' relationships with DSMBs that aren't as independent as this one.)
-
But that's just what you would expect given low numbers and low precision anyway. It's just a bizarre thing to do, I can't see the rationale at all
- Show replies
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.